Long term intake of 0.1% ethanol decreases serum adiponectin by suppressing PPARγ expression via p38 MAPK pathway

Food and Chemical Toxicology

Volumn 65, Issue , 2014, Pages 329-334

  Tian, Chong ^a   Jin, Xin ^a   Ye, Xiaolei ^b   Wu, Hongmei ^b   Ren, Weiye ^a   Zhang, Rui ^a   Long, Jia ^a   Ying, Chenjiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Adiponectin; Ethanol; Long term exposure; P38 MAPK; PPAR

Indexed keywords

ADIPONECTIN; ETHANOL; LONG-TERM EXPOSURE; P38 MAPK; PPARΓ;

ADIPONECTIN; ANIMALS; BASE SEQUENCE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHANOL; INTRA-ABDOMINAL FAT; MALE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PPAR GAMMA; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

2 CHLORO 5 NITROBENZANILIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADIPONECTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; IN VIVO STUDY; INTRAABDOMINAL FAT; LONG TERM EXPOSURE; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 84893429347     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2014.01.007     Document Type: Article

References (43)

1. Arky R.A., Veverbrants E., Abramson E.A. Irreversible Hypoglycemia: A Complication of Alcohol and Insulin. JAMA 1968, 206(3):575-578.
2. Aroor A.R., Shukla S.D. MAP kinase signaling in diverse effects of ethanol. Life Sci. 2004, 74(19):2339-2364.
3. Aroor A.R., Jackson D.E., Shukla S.D. Elevated activation of ERK1 and ERK2 accompany enhanced liver injury following alcohol binge in chronically ethanol-fed rats. Alcohol Clin. Exp. Res. 2011, 35(12):2128-2138.
4. Banga A., Unal R., Tripathi P., Pokrovskaya I., Owens R.J., Kern P.A., Ranganathan G. Adiponectin translation is increased by the PPARgamma agonists pioglitazone and omega-3 fatty acids. Am J Physiol Endocrinol Metab. 2009, 296(3):E480-E489.
5. Catalano P.M., Nizielski S.E., Shao J., Preston L., Qiao L., Friedman J.E. Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy. Am. J. Physiol. Endocrinol. Metab. 2002, 282(3):E522-E533.
6. Chen X., Sebastian B.M., Nagy L.E. Chronic ethanol feeding to rats decreases adiponectin secretion by subcutaneous adipocytes. Am. J. Physiol. Endocrinol. Metab. 2007, 292(2):E621-E628.
7. Chen X., Sebastian B.M., Tang H., McMullen M.M., Axhemi A., Jacobsen D.W., Nagy L.E. Taurine supplementation prevents ethanol-induced decrease in serum adiponectin and reduces hepatic steatosis in rats. Hepatology 2009, 49(5):1554-1562.
8. Chen C.Y., Asakura M., Asanuma H., Hasegawa T., Tanaka J., Toh N., Min K.D., Kanzaki H., Takahama H., Amaki M., Itoh Y., Ichien G., Okumoto Y., Funahashi T., Kim J., Kitakaze M. Plasma adiponectin levels predict cardiovascular events in the observational Arita Cohort Study in Japan: the importance of the plasma adiponectin levels. Hypertens. Res. 2012, 35(8):843-848.
9. Combs T.P., Wagner J.A., Berger J., Doebber T., Wang W.J., Zhang B.B., Tanen M., Berg A.H., O'Rahilly S., Savage D.B., Chatterjee K., Weiss S., Larson P.J., Gottesdiener K.M., Gertz B.J., Charron M.J., Scherer P.E., Moller D.E. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 2002, 143(3):998-1007.
10. Fillmore K.M., Stockwell T., Chikritzhs T., Bostrom A., Kerr W. Moderate alcohol use and reduced mortality risk: systematic error in prospective studies and new hypotheses. Ann. Epidemiol. 2007, 17(5 Suppl):S16-S23.
11. Goral J., Choudhry M.A., Kovacs E.J. Acute ethanol exposure inhibits macrophage IL-6 production: role of p38 and ERK1/2 MAPK. J. Leukoc. Biol. 2004, 75(3):553-559.
12. Gu L., Fink A.M., Chowdhury S.A., Geenen D.L., Piano M.R. Cardiovascular responses and differential changes in mitogen-activated protein kinases following repeated episodes of binge drinking. Alcohol 2013, 48(2):131-137.
13. Iwaki M., Matsuda M., Maeda N., Funahashi T., Matsuzawa Y., Makishima M., Shimomura I. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003, 52(7):1655-1663.
14. Iwashima Y., Katsuya T., Ishikawa K., Kida I., Ohishi M., Horio T., Ouchi N., Ohashi K., Kihara S., Funahashi T., Rakugi H., Ogihara T. Association of hypoadiponectinemia with smoking habit in men. Hypertension 2005, 45(6):1094-1100.
15. Jung S.K., Kim M.K., Shin J., Choi B.Y. A cross-sectional analysis of the relationship between daily alcohol consumption and serum adiponectin levels among adults aged 40 years or more in a rural area of Korea. Eur. J. Clin. Nutr. 2013, 67(8):841-847.
16. Kang L., Sebastian B.M., Pritchard M.T., Pratt B.T., Previs S.F., Nagy L.E. Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines. Alcohol Clin. Exp. Res. 2007, 31(9):1581-1588.
17. Kawamura Y., Tanaka Y., Kawamori R., Maeda S. Overexpression of Kruppel-like factor 7 regulates adipocytokine gene expressions in human adipocytes and inhibits glucose-induced insulin secretion in pancreatic beta-cell line. Mol. Endocrinol. 2006, 20(4):844-856.
18. Kupfer D.M., White V.L., Strayer D.L., Crouch D.J., Burian D. Microarray characterization of gene expression changes in blood during acute ethanol exposure. BMC Med. Genomics 2013, 6:26.
19. Kursawe R., Narayan D., Cali A.M., Shaw M., Pierpont B., Shulman G.I., Caprio S. Downregulation of ADIPOQ and PPARgamma2 gene expression in subcutaneous adipose tissue of obese adolescents with hepatic steatosis. Obesity (Silver Spring) 2010, 18(10):1911-1917.
20. Lippi G., Franchini M., Favaloro E.J., Targher G. Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox". Semin. Thromb. Hemost. 2010, 36(1):59-70.
21. Liu M., Liu F. Transcriptional and post-translational regulation of adiponectin. Biochem. J. 2009, 425(1):41-52.
22. Majuri A., Santaniemi M., Rautio K., Kunnari A., Vartiainen J., Ruokonen A., Kesäniemi Y.A., Tapanainen J.S., Ukkola O., Morin-Papunen L. Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study. Eur. J. Endocrinol. 2007, 156(2):263-269.
23. Min Y., Robert V.C., Teresa C.L., Daniel P.K., David W.C. The role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 2005, 42(3):568-577.
24. Mortensen E.L., Jensen H.H., Sanders S.A., Reinisch J.M. Better psychological functioning and higher social status may largely explain the apparent health benefits of wine: a study of wine and beer drinking in young Danish adults. Arch. Intern. Med. 2001, 161(15):1844-1848.
25. Naimi T.S., Brown D.W., Brewer R.D., Giles W.H., Mensah G., Serdula M.K., Mokdad A.H., Hungerford D.W., Lando J., Naimi S., Stroup D.F. Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults. Am. J. Prev. Med. 2005, 28(4):369-373.
26. Ogawa Y., Kikuchi T., Nagasaki K., Hiura M., Tanaka Y., Uchiyama M. Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children. Hypertens. Res. 2005, 28(1):51-57.
27. Ohshima K., Mogi M., Jing F., Iwanami J., Tsukuda K., Min L.J., Ogimoto A., Dahlöf B., Steckelings U.M., Unger T., Higaki J., Horiuchi M. Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARγ activation. PLoS One 2012, 7(11):e48387.
28. Petersen R.K., Larsen S.B., Jensen D.M., Christensen J., Olsen A., Loft S., Nellemann C., Overvad K., Kristiansen K., Tjonneland A., Vogel U. PPARgamma-PGC-1alpha activity is determinant of alcohol related breast cancer. Cancer Lett. 2012, 315(1):59-68.
29. Player M.S., Mainous A.G., King D.E., Diaz V.A., Everett C.J. Moderate alcohol intake is associated with decreased risk of insulin resistance among individuals with vitamin D insufficiency. Nutrition 2010, 26(1):100-105.
30. Plumlee C.R., Lazaro C.A., Fausto N., Polyak S.J. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells. Virol. J. 2005, 2:89.
31. Semple R.K., Cochran E.K., Soos M.A., Burling K.A., Savage D.B., Gorden P., O'Rahilly S. Plasma adiponectin as a marker of insulin receptor dysfunction: clinical utility in severe insulin resistance. Diabetes Care 2008, 31(5):977-979.
32. Song Z., Zhou Z., Deaciuc I., Chen T., McClain C.J. Inhibition of adiponectin production by homocysteine: a potential mechanism for alcoholic liver disease. Hepatology 2008, 47(3):867-879.
33. Stanton L.A., Li J.R., Beier F. PPARgamma2 expression in growth plate chondrocytes is regulated by p38 and GSK-3. J. Cell. Mol. Med. 2010, 14(1-2):242-256.
34. Stockwell T., Chikritzhs T., Bostrom A., Fillmore K., Kerr W., Rehm J., Taylor B. Alcohol-caused mortality in australia and Canada: scenario analyses using different assumptions about cardiac benefit. J. Stud. Alcohol Drugs 2007, 68(3):345-352.
35. Sun X., Tang Y., Tan X., Li Q., Zhong W., Sun X., Jia W., McClain C.J., Zhou Z. Activation of peroxisome proliferator-activated receptor-γ by rosiglitazone improves lipid homeostasis at the adipose tissue-liver axis in ethanol-fed mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 302(5):G548-G557.
36. Szuster-Ciesielska A., Mizerska-Dudka M., Daniluk J., Kandefer-Szerszeń M. Butein inhibits ethanol-induced activation of liver stellate cells through TGF-β, NFκB, p38, and JNK signaling pathways and inhibition of oxidative stress. J. Gastroenterol. 2013, 48(2):222-237.
37. Tian C., Ye X., Zhang R., Long J., Ren W., Ding S., Liao D., Jin X., Wu H., Xu S., Ying C. Green tea polyphenols reduced fat deposits in high fat-fed rats via erk1/2-PPARγ-adiponectin pathway. PLoS One 2013, 8(1):e53796.
38. Wakabayashi I., Kobaba-Wakabayashi R. Effects of age on the relationship between drinking and atherosclerotic risk factors. Gerontology 2002, 48(3):151-156.
39. Wannamethee S.G., Shaper A.G., Whincup P.H. Alcohol and adiposity: effects of quantity and type of drink and time relation with meals. Int. J. Obes. (Lond) 2005, 29(12):1436-1444.
40. Yang W.S., Jeng C.Y., Wu T.J., Tanaka S., Funahashi T., Matsuzawa Y., Wang J.P., Chen C.L., Tai T.Y., Chuang L.M. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 2002, 25(2):376-380.
41. Yang Q., Chen C., Wu S., Zhang Y., Mao X., Wang W. Advanced glycation end products downregulates peroxisome proliferator-activated receptor gamma expression in cultured rabbit chondrocyte through MAPK pathway. Eur. J. Pharmacol. 2010, 649(1-3):108-114.
42. Yu H.C., Li S.Y., Cao M.F., Jiang X.Y., Feng L., Zhao J.J., Gao L. Effects of chronic ethanol consumption on levels of adipokines in visceral adipose tissues and sera of rats. Acta Pharmacol. Sin. 2010, 31(4):461-469.
43. Zeng T., Zhang C.L., Song F.Y., Zhao X.L., Yu L.H., Zhu Z.P., Xie K.Q. The activation of HO-1/Nrf-2 contributes to the protective effects of diallyl disulfide (DADS) against ethanol-induced oxidative stress. Biochim. Biophys. Acta 2013, 1830(10):4848-4859.